PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis.

MLA

Burgess, Heather A., et al. “PPARgamma Agonists Inhibit TGF-Beta Induced Pulmonary Myofibroblast Differentiation and Collagen Production: Implications for Therapy of Lung Fibrosis.” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 288, no. 6, June 2005, pp. L1146–53. EBSCOhost, https://doi.org/10.1152/ajplung.00383.2004.

APA

Burgess, H. A., Daugherty, L. E., Thatcher, T. H., Lakatos, H. F., Ray, D. M., Redonnet, M., Phipps, R. P., & Sime, P. J. (2005). PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology, 288(6), L1146–L1153. https://doi.org/10.1152/ajplung.00383.2004

Chicago

Burgess, Heather A, Louis Eugene Daugherty, Thomas H Thatcher, Heather F Lakatos, Denise M Ray, Michelle Redonnet, Richard P Phipps, and Patricia J Sime. 2005. “PPARgamma Agonists Inhibit TGF-Beta Induced Pulmonary Myofibroblast Differentiation and Collagen Production: Implications for Therapy of Lung Fibrosis.” American Journal of Physiology. Lung Cellular and Molecular Physiology 288 (6): L1146–53. doi:10.1152/ajplung.00383.2004.